Insmed has launched a first-in-human Phase 1 trial testing its experimental ALS gene therapy INS1202 in people with the disease.
Johns Hopkins’s Center for Immunization Research is enrolling otherwise healthy medical subjects to be injected and infected with Zika, the virus associated with microcephaly that created a global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results